Shares of Uranium Energy Corp (UEC.US), a leading U.S. uranium producer, are losing nearly 4% at the open today. The declines come despite news that it has received $17.85 million from the U.S. Department of Energy:
- The sale to the DoE took place at a price of $59.50 per pound and was nearly 50% higher than the spot price of U308, which is currently around $40. For a while, it was above $50 in 2021;
- With the December 2022 contract, UEC delivered 300,000 pounds of enriched U3O8, as part of its strategic uranium reserve program. The raw material was entirely of US origin;
- U.S. enriched uranium production is almost entirely dominated by UEC. Until now, the country has relied on supplies from Russia and Canada. Now the U.S. is expected to focus on securing domestic supplies and supporting domestic producers;
- According to the company's CEO, Amir Adnani, the company can count on continued purchases by the DoE under the 'Uranium Reserve' program in future years.
Uranium Energy Corp (UEC.US) shares, D1 interval. The company's stock has been trading between the 61.8 and 38.2 Fibonacci retracements of the upward wave that began in March 2020. The SMA100 average (black) has again crossed the SMA200 (red), which may indicate a longer-term weakening of bullish strength. Important levels in case of declines may turn out to be $2.7 and $2.1 where the local price minima of 2021 and the peaks of 2020 are located. On the other hand, if buyers regain control, a retest of the 38.2 retracement at $4.15 is not excluded, which could open the way to $5 per share. Source: xStation5
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
